Page 62 - Annual Report 2020
P. 62

   The Hormel Institute // JULY 1, 2019 – JUNE 30, 2020
PUBLICATIONS
  H.I. No. 2301 Cholangiocarcinoma 2020: The Next Horizon in Mechanisms and Management. Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., ... Gradilone, S. A., ... Gores, G. J. Nat Rev Gastroenterol Hepatol. (2020).
H.I. No. 2302 Emerging Roles for Human Glycolipid Transfer Protein Superfamily Members in the Reg- ulation of Autophagy, Inflammation, and Cell Death. Mishra, S. K., Gao, Y. G., Zou, X., Stephenson, D.
J., Malinina, L., Hinchcliffe, E. H., Chalfant, C. E., & Brown, R. E. Prog Lipid Res, 78, 101031. (2020).
H.I. No. 2303 New Synthetic Conjugates of Ursode- oxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease. Caballero-Cami- no, F. J., Rivilla, I., Herraez, E., Briz, O., Santos-Laso, A., Izquierdo-Sanchez, L., Lee-Law, P. Y., Rodrigues, P. M., Munoz-Garrido, P., Jin, S., Peixoto, E., Rich- ard, S., Gradilone, S. A., Perugorria, M. J., Esteller, M., Bujanda, L., Marin, J. J. G., Banales, J. M., & Cossio, F. P. Hepatology. (2020).
H.I. No. 2304 Liquid Phase Condensation Directs Nucleosome Epigenetic Modifications. Yang, Y., & Yu, C. Signal Transduct Target Ther, 5(1), 64. (2020).
H.I. No. 2305 Drp1-Dependent Remodeling of Mitochondrial Morphology Triggered by Ebv-Lmp1 Increases Cisplatin Resistance. Xie, L., Shi, F., Li,
Y., Li, W., Yu, X., Zhao, L., Zhou, M., Hu, J., Luo, X., Tang, M., Fan, J., Zhou, J., Gao, Q., Wu, W., Zhang, X., Liao, W., Bode, A. M., & Cao, Y. Signal Transduct Target Ther, 5(1), 56. (2020).
H.I. No. 2306 Protein Lysine 43 Methylation by Ezh1 Promotes Aml1-Eto Transcriptional Repression in Leukemia. Dou, L., Yan, F., Pang, J., Zheng, D., Li, D., Gao, L., Wang, L., Xu, Y., Shi, J., Wang, Q., Zhou, L., Shen, N., Singh, P., Wang, L., Li, Y., Gao, Y., Liu, T., Chen, C., Al-Kali, A., Litzow, M. R., Chi, Y. I., Bode, A. M., Liu, C., Huang, H., Liu, D., Marcucci, G., Liu, S., & Yu, L. Nat Commun, 10(1), 5051. (2019).
H.I. No. 2307 Structural Basis of Host Protein Hijacking in Human T-Cell Leukemia Virus Integration. Bhatt, V., Shi, K., Salamango, D. J., Moeller, N. H., Pandey, K. K., Bera, S., Bohl, T. E., Kurniawan, F., Orellana, K., Zhang, W., Grandgenett, D. P., Harris, R. S., Sundborger-Lunna, A. C., & Aihara, H. Nat Commun, 11(1), 3121. (2020).
H.I. No. 2308 Structure of the Human Lipid Exporter Abcb4 in a Lipid Environment. Olsen, J. A., Alam, A., Kowal, J., Stieger, B., & Locher, K. P. Nat Struct Mol Biol, 27(1), 62-70. (2020).
H.I. No. 2309 Diverse Ar Gene Rearrangements Me- diate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer. Li, Y., Yang, R., Henzler, C. M., Ho, Y., Passow, C., Auch, B., Carreira, S., Nava
Rodrigues, D., Bertan, C., Hwang, T. H., Quigley, D. A., Dang, H. X., Morrissey, C., Fraser, M., Plymate, S. R., Maher, C. A., Feng, F. Y., de Bono, J. S., & Dehm, S. M. Clin Cancer Res, 26(8), 1965-1976. (2020).
H.I. No. 2310 Structural Basis of Bacterial Σ(28) -Mediated Transcription Reveals Roles of the Rna Polymerase Zinc-Binding Domain. Shi, W., Zhou, W., Zhang, B., Huang, S., Jiang, Y., Schammel, A., Hu, Y., & Liu, B. Embo j, 39(14), e104389. (2020).
H.I. No. 2311 Lysosomal Degradation Ensures Accurate Chromosomal Segregation to Prevent Chromosomal Instability. Almacellas, E., Pelletier, J., Day, C., Ambrosio, S., Tauler, A., & Mauvezin, C. Autophagy, 1-18. (2020).
H.I. No. 2312 Cdk12 and Pak2 as Novel Therapeutic Targets for Human Gastric Cancer. Liu, H., Shin, S. H., Chen, H., Liu, T., Li, Z., Hu, Y., Liu, F., Zhang, C., Kim, D. J., Liu, K., & Dong, Z. Theranostics, 10(14), 6201-6215. (2020).
H.I. No. 2313 Suppression of the Solar Ultravio- let-Induced Skin Carcinogenesis by Topk Inhibitor Hi- Topk-032. Roh, E., Han, Y., Reddy, K., Zykova, T. A., Lee, M. H., Yao, K., Bai, R., Curiel-Lewandrowski, C., & Dong, Z. Oncogene, 39(21), 4170-4182. (2020).
H.I. No. 2314 Hexosamine Pathway Inhibition Overcomes Pancreatic Cancer Resistance to Gem- citabine through Unfolded Protein Response and Egfr-Akt Pathway Modulation. Ricciardiello, F., Gang, Y., Palorini, R., Li, Q., Giampà, M., Zhao, F., You, L., La Ferla, B., De Vitto, H., Guan, W., Gu, J., Zhang,
T., Zhao, Y., & Chiaradonna, F. Oncogene, 39(20), 4103-4117. (2020).
H.I. No. 2315 Cancer Cell-Derived Long Pentraxin 3 (Ptx3) Promotes Melanoma Migration through a Toll- Like Receptor 4 (Tlr4)/Nf-Kappab Signaling Pathway. Rathore, M., Girard, C., Ohanna, M., Tichet, M., Ben Jouira, R., Garcia, E., Larbret, F., Gesson, M., Aude- bert, S., Lacour, J. P., Montaudie, H., Prod’Homme, V., Tartare-Deckert, S., & Deckert, M. Oncogene, 38(30), 5873-5889. (2019).
H.I. No. 2316 Visualization of Two Architectures in Class-Ii Cap-Dependent Transcription Activation. Shi, W., Jiang, Y., Deng, Y., Dong, Z., & Liu, B. PLoS Biol, 18(4), e3000706. (2020).
H.I. No. 2317 Acetylshikonin Suppressed Growth
of Colorectal Tumour Tissue and Cells by Inhibiting the Intracellular Kinase, T-Lymphokine-Activated Killer Cell-Originated Protein Kinase. Zhao, R., Choi, B. Y., Wei, L., Fredimoses, M., Yin, F., Fu, X., Chen, H., Liu, K., Kundu, J. K., Dong, Z., & Lee, M. H. Br J Pharma- col, 177(10), 2303-2319. (2020).
H.I. No. 2318 Measuring Lipid Transfer Protein Activity Using Bicelle-Dilution Model Membranes. Gao, Y. G., My Le, L. T., Zhai, X., Boldyrev, I. A., Mishra, S. K., Tischer, A., Murayama, T., Nishida, A., Molotkovsky, J. G., Alam, A., & Brown, R. E. Anal Chem, 92(4), 3417-3425. (2020).
H.I. No. 2319 The Interaction of Ceramide 1-Phosphate with Group Iva Cytosolic Phospholipase A2 Coordinates Acute Wound Healing and Repair. MacKnight, H. P., Stephenson, D. J., Hoeferlin, L. A., Benusa, S. D., DeLigio, J. T., Maus, K. D., Ali, A. N., Wayne, J. S., Park, M. A., Hinchcliffe, E. H., Brown, R. E., Ryan, J. J., Diegelmann, R. F., & Chalfant, C. E. Sci Signal, 12(610). (2019).
H.I. No. 2320 Wild-Type Idh2 Contributes to Epstein-Barr Virus-Dependent Metabolic Alterations and Tumorigenesis. Shi, F., He, Y., Li, J., Tang, M.,
Li, Y., Xie, L., Zhao, L., Hu, J., Luo, X., Zhou, M., Liu, N., Fan, J., Zhou, J., Gao, Q., Qiu, S., Wu, W., Zhang, X., Jia, W., Bode, A. M., & Cao, Y. Mol Metab, 36, 100966. (2020).
H.I. No. 2321 Induction and Prevention of Gastric Cancer with Combined Helicobacter Pylori and Capsaicin Administration and Dfmo Treatment, Respectively. Aziz, F., Xin, M., Gao, Y., Chakroborty, A., Khan, I., Monts, J., Monson, K., Bode, A. M., & Dong, Z. Cancers (Basel), 12(4). (2020).
H.I. No. 2322 Ascl1-Regulated Darpp-32 and T-Darpp Stimulate Small Cell Lung Cancer Growth and Neuroendocrine Tumour Cell Proliferation. Alam, S. K., Wang, L., Ren, Y., Hernandez, C. E., Kosari,
F., Roden, A. C., Yang, R., & Hoeppner, L. H. Br J Cancer. (2020).
H.I. No. 2323 Targeting the Cox1/2-Driven Throm- boxane A2 Pathway Suppresses Barrett’s Esophagus and Esophageal Adenocarcinoma Development. Zhang, T., Wang, Q., Ma, W. Y., Wang, K., Chang,
X., Johnson, M. L., Bai, R., Bode, A. M., Foster, N. R., Falk, G. W., Limburg, P. J., Iyer, P. G., & Dong, Z. EBioMedicine, 49, 145-156. (2019).
H.I. No. 2324 Knock-Down of the Tim/Tipin Complex Promotes Apoptosis in Melanoma Cells. Chakraborty, A., Aziz, F., Roh, E., Le, L. T. M., Dey, R., Zhang, T., Rathore, M. G., Biswas, A. S., Bode, A. M., & Dong, Z. Oncotarget, 11(20), 1846-1861. (2020).
H.I. No. 2325 Function and Regulation of Il-36 Signaling in Inflammatory Diseases and Cancer Development. Queen, D., Ediriweera, C., & Liu, L. Front Cell Dev Biol, 7, 317. (2019).
H.I. No. 2326 Evolution of Ty1 Copy Number Con- trol in Yeast by Horizontal Transfer and Recombina- tion. Czaja, W., Bensasson, D., Ahn, H. W., Garfinkel, D. J., & Bergman, C. M. Plos Genetics, 16(2). (2020).
H.I. No. 2327 Targeted Therapy of the Akt Kinase Inhibits Esophageal Squamous Cell Carcinoma Growth in Vitro and in Vivo. Liu, X., Song, M., Wang, P., Zhao, R., Chen, H., Zhang, M., Shi, Y., Liu, K., Liu, F., Yang, R., Li, E., Bode, A. M., Dong, Z., & Lee, M. H. Int J Cancer, 145(4), 1007-1019. (2019).
H.I. No. 2328 Fuzzy Modeling and Global Optimiza- tion to Predict Novel Therapeutic Targets in Cancer Cells. Nobile, M. S., Votta, G., Palorini, R., Spolaor, S., De Vitto, H., Cazzaniga, P., Ricciardiello, F., Mauri, G., Alberghina, L., Chiaradonna, F., & Be- sozzi, D. Bioinformatics, 36(7), 2181-2188. (2020).
H.I. No. 2329 Analysis of Hydrophobic and Hydro- philic Moments of Short Penetrating Peptides for Enhancing Mitochondrial Localization: Prediction and Validation. Pirisinu, M., Blasco, P., Tian, X., Sen, Y., Bode, A. M., Liu, K., & Dong, Z. Faseb J, 33(7), 7970-7984. (2019).
H.I. No. 2330 Protein Diaphanous Homolog 1 (Diaph1) Promotes Myofibroblastic Activation of Hepatic Stellate Cells by Regulating Rab5a Activity and Tgfβ Receptor Endocytosis. Liu, D., Fu, X., Wang, Y., Wang, X., Wang, H., Wen, J., & Kang, N. Faseb J, 34(6), 7345-7359. (2020).
H.I. No. 2331 Role of Histone Deacetylases in Car- cinogenesis: Potential Role in Cholangiocarcinoma. Pant, K., Peixoto, E., Richard, S., & Gradilone, S. A. Cells, 9(3). (2020).
H.I. No. 2332 Celf2 Suppresses Non-Small Cell Lung Carcinoma Growth by Inhibiting the Prex2-Pten Interaction. Yeung, Y. T., Fan, S., Lu, B., Yin, S., Yang, S., Nie, W., Wang, M., Zhou, L., Li, T., Li, X., Bode,
A. M., & Dong, Z. Carcinogenesis, 41(3), 377-389. (2020).
H.I. No. 2333 N,P-Doped Carbon Nanodots for Food-Matrix Decontamination, Anticancer Potential, and Cellular Bio-Imaging Applications. Bajpai, V. K., Khan, I., Shukla, S., Kumar, P., Chen, L., Anand, S. R., Tripathi, K. M., Bhati, A., Kang, S.-M., Lee, H., Kwak, C. H., Huang, M., Sonkar, S. K., Huh, Y. S., & Han, Y.-K. Journal of Biomedical Nanotechnology, 16(3), 283-303. (2020).
H.I. No. 2334 Mechanotransduction in Liver Diseas- es. Kang, N. Semin Liver Dis, 40(1), 84-90. (2020).
H.I. No. 2335 An Engineered Aav6-Based Vaccine Induces High Cytolytic Anti-Tumor Activity by Directly Targeting Dcs and Improves Ag Presentation. Kroto- va, K., Day, A., & Aslanidi, G. Mol Ther Oncolytics, 15, 166-177. (2019).
H.I. No. 2336 Modifiers of Adeno-Associated Virus-Mediated Gene Expression in Implication for Serotype-Universal Neutralizing Antibody Assay. Krotova, K., & Aslanidi, G. Hum Gene Ther. (2020).




















































   60   61   62   63   64